BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23083609)

  • 1. Economic aspects of MR-mammography in dense breasts.
    Kaiser CG; Reich C; Wasser K; Schönberg SO; Kaiser WA
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S69-71. PubMed ID: 23083609
    [No Abstract]   [Full Text] [Related]  

  • 2. Potential Cost Savings of Contrast-Enhanced Digital Mammography.
    Patel BK; Gray RJ; Pockaj BA
    AJR Am J Roentgenol; 2017 Jun; 208(6):W231-W237. PubMed ID: 28379734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mammography screening in Germany: how, when and why?].
    Bick U
    Rofo; 2006 Oct; 178(10):957-69. PubMed ID: 17021975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cost-effectiveness of MR-imaging in the preoperative work-up of suspicious breast lesions].
    Schmitt KP; Boehm T; Fleck M; Kaiser WA
    Rofo; 2001 Oct; 173(10):898-901. PubMed ID: 11588676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A brief commentary on cost-effectiveness analysis in radiologic research.
    Poon CS
    AJR Am J Roentgenol; 2008 Nov; 191(5):1320-2. PubMed ID: 18941063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening.
    Feig S
    Radiol Clin North Am; 2010 Sep; 48(5):879-91. PubMed ID: 20868891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimal use of MRI mammography from the economic viewpoint].
    Oellinger H; Blohmer JU; Siewert C; Hadijuana J; Gutberlet M; Ehrenstein T; Lichtenegger W; Felix R
    Zentralbl Chir; 1998; 123 Suppl 5():42-6. PubMed ID: 10063571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of costs and benefits of breast cancer screening with mammography, ultrasonography, and MRI.
    Feig S
    Obstet Gynecol Clin North Am; 2011 Mar; 38(1):179-96, ix. PubMed ID: 21419333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Magnetic resonance imaging of the breast: costs and efficiency].
    Golder WA
    Onkologie; 2001 Apr; 24(2):185-8. PubMed ID: 11441302
    [No Abstract]   [Full Text] [Related]  

  • 10. Cost-effectiveness of MR imaging and core-needle biopsy in the preoperative work-up of suspicious breast lesions.
    Hrung JM; Langlotz CP; Orel SG; Fox KR; Schnall MD; Schwartz JS
    Radiology; 1999 Oct; 213(1):39-49. PubMed ID: 10540638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of Cost-effectiveness of screening for breast cancer with conventional mammography, digital and magnetic resonance imaging].
    Peregrino AA; Vianna CM; de Almeida CE; Gonzáles GB; Machado SC; Costa e Silva FV; Rodrigues MP
    Cien Saude Colet; 2012 Jan; 17(1):215-22. PubMed ID: 22218554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cost effectiveness of telemedicine].
    Christiansen S; Klötzer JP
    Versicherungsmedizin; 2015 Dec; 67(4):193-6. PubMed ID: 26775309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A quest for quality and economic effectiveness throughout the continuum of breast care.
    La Fargue MM; Coleman C
    Breast; 2010 Aug; 19(4):251-2. PubMed ID: 20392641
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of magnetic resonance imaging in breast cancer screening.
    Lee CH; Weinreb JC
    J Am Coll Radiol; 2004 Mar; 1(3):176-82. PubMed ID: 17411555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging.
    Saadatmand S; Tilanus-Linthorst MM; Rutgers EJ; Hoogerbrugge N; Oosterwijk JC; Tollenaar RA; Hooning M; Loo CE; Obdeijn IM; Heijnsdijk EA; de Koning HJ
    J Natl Cancer Inst; 2013 Sep; 105(17):1314-21. PubMed ID: 23940285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of MR-mammography as a solitary imaging technique in women with dense breasts: an economic evaluation of the prospective TK-Study.
    Froelich MF; Kaiser CG
    Eur Radiol; 2021 Feb; 31(2):967-974. PubMed ID: 32856166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are breast biopsies adequately funded? A process cost & revenue analysis].
    Hahn M; Fischbach E; Fehm T; Rothmund R; Siegmann KC; Scheich D; Heywang-Koebrunner SH; Jennissen JJ; Murauer M; Krapfl E; Landwehr P; Fronhoff K; Scheler P; Schreer I; Solomayer EF; Wallwiener D
    Rofo; 2011 Apr; 183(4):347-57. PubMed ID: 21113867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR imaging: effectiveness and costs at triage of patients with nonacute knee symptoms.
    Vincken PW; ter Braak AP; van Erkel AR; Coerkamp EG; de Rooy TP; de Lange S; Mallens WM; Coene LN; Bloem RM; van Luijt PA; van den Hout WB; van Houwelingen HC; Bloem JL
    Radiology; 2007 Jan; 242(1):85-93. PubMed ID: 17090714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mammographic screening for breast cancer: An invited review of the benefits and costs.
    Greif JM
    Breast; 2010 Aug; 19(4):268-72. PubMed ID: 20371181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.